fda gilead - Search News

News

FDA Approves Gilead’s HIV Shot. It Works 99.9% of Time.

USA TODAY on MSN · 5h

FDA approves new twice-yearly HIV shot. What to know

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

Discover Magazine · 16m

FDA Approves Breakthrough HIV Drug, but It Could Be Hard to Access

Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.

Barron's on MSN · 1d

FDA Approves Gilead’s HIV Shot. It Works 99.9% of the Time.

The Food and Drug Administration approved a twice-yearly shot that prevented HIV infections in 99.9% of the people who received it in large clinical trials. The drug, developed by Gilead Sciences and called Yeztugo,

42m

Scientists develop new drug for virus affecting lakhs each year, offers 99.9% protection with two injections, it is priced at Rs...

More than a million people are infected every year with the Human Immunodeficiency Virus (HIV), despite decades of work ...

Fierce Pharma1d

FDA signs off on Gilead’s landmark long-acting PrEP med, signaling new era in HIV prevention

With the FDA’s much-anticipated nod for Gilead Sciences’ long-acting HIV pre-exposure prophylaxis (PrEP) injection Yeztugo ...

1d

Should You Buy Gilead Stock At $110?

Gilead Sciences (NASDAQ:GILD) has demonstrated a strong performance this year, with its stock up 18% compared to the S&P ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results